These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Congenital hyperinsulinism in newborn and infant]. Giurgea I, Ribeiro MJ, Boddaert N, Touati G, Robert JJ, Saudubray JM, Jaubert F, Bellanné-Chantelot C, Brunelle F, Nihoul-Fékété C, de Lonlay P. Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094 [Abstract] [Full Text] [Related]
4. Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism. Suchi M, MacMullen CM, Thornton PS, Adzick NS, Ganguly A, Ruchelli ED, Stanley CA. Mod Pathol; 2006 Jan; 19(1):122-9. PubMed ID: 16357843 [Abstract] [Full Text] [Related]
7. A multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy. Adzick NS, Thornton PS, Stanley CA, Kaye RD, Ruchelli E. J Pediatr Surg; 2004 Mar; 39(3):270-5. PubMed ID: 15017536 [Abstract] [Full Text] [Related]
10. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. Verkarre V, Fournet JC, de Lonlay P, Gross-Morand MS, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fékété C, Saudubray JM, Junien C. J Clin Invest; 1998 Oct 01; 102(7):1286-91. PubMed ID: 9769320 [Abstract] [Full Text] [Related]
11. KATP channel mutations in congenital hyperinsulinism. Saint-Martin C, Arnoux JB, de Lonlay P, Bellanné-Chantelot C. Semin Pediatr Surg; 2011 Feb 01; 20(1):18-22. PubMed ID: 21185999 [Abstract] [Full Text] [Related]
12. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. Grimberg A, Ferry RJ, Kelly A, Koo-McCoy S, Polonsky K, Glaser B, Permutt MA, Aguilar-Bryan L, Stafford D, Thornton PS, Baker L, Stanley CA. Diabetes; 2001 Feb 01; 50(2):322-8. PubMed ID: 11272143 [Abstract] [Full Text] [Related]
13. The Knudson's two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism. Giurgea I, Sempoux C, Bellanné-Chantelot C, Ribeiro M, Hubert L, Boddaert N, Saudubray JM, Robert JJ, Brunelle F, Rahier J, Jaubert F, Nihoul-Fékété C, de Lonlay P. J Clin Endocrinol Metab; 2006 Oct 01; 91(10):4118-23. PubMed ID: 16882742 [Abstract] [Full Text] [Related]